The global particle therapy market size stood at $814.1 million in 2021, which is expected to reach $1,741.4 million by 2030, propelling at a CAGR of 9.1% during 2021�2030.
Particle therapy is a medical treatment that employs the use of microscopic particles to destroy cancerous cells. Particle therapy is used to treat a variety of cancers, including: -Lung cancer-Cancer of the colorectum (the large intestine) -Ovarian cancer-Testicular cancer -Prostate cancer -Rare cancers such as medulloblastoma and Ewing's sarcoma. The particle therapy machine generates tiny particles called "particles" using radiofrequency or microwave energy.
The particles are then directed at the tumor of interest. Cancer cells are attacked and destroyed by the particles. This has the potential to cause tumour shrinkage and death. Particle therapy has been shown in some studies to be more effective than traditional chemotherapy in treating certain types of cancer.
Market Dynamics
Drivers:
Particle therapy has seen significant technological advancements in recent years. These developments have enabled manufacturers to create more effective and controlled particle therapy systems that are less invasive, deliver lower levels of radiation to healthy tissues, and have fewer side effects.
Particle therapy, particularly proton therapy, has several advantages over photon therapy. These advantages are propelling the growth of this market, particularly in mature markets where technologically advanced products are widely adopted. Some advantages of particle therapy over traditional photon-based therapy are listed below.
• More precisely targets tumours and cancer cells
• Less energy is released, and a lower exit dose is used, lowering the risk of damage to healthy tissues and organs
• Lowers overall toxicity and the likelihood and/or severity of short- and long-term side effects on surrounding healthy tissues and organs, lowering the likelihood of secondary tumours caused by the treatment.
Restraints:
Particle therapy systems are expensive and require sophisticated infrastructure to install. Because these devices (including cyclotrons and synchrotrons) are larger than photon therapy systems, they require more space to be installed.
Construction, maintenance, staffing, and operating costs for particle therapy facilities are significant. As a result, only a small number of healthcare institutions in developing and underdeveloped countries are equipped to use advanced particle therapy systems. Under-equipped healthcare facilities due to limited healthcare expenditure are one of the major factors impeding particle therapy system adoption, limiting the number of particle beam therapy procedures despite their high demand.
Key players:
-
IBA Worldwide
Market Segmentation:
Particle Therapy Market, Based on Type
Particle Therapy Market, Based on Product & Service
Particle Therapy Market, Based on System
Particle Therapy Market, Based on Cancer Type
Particle Therapy Market, Based on Application
Particle Therapy Market, Based on End User
-
Hospitals
Particle Therapy Market, Geographical Analysis
-
North America
-
Europe
-
Asia-Pacific
-
Latin America
-
Middle East and Africa
Regional Analysis:
In 2021, the Asia Pacific region will hold 34% of the market. During the forecast period, the Asia Pacific market will grow at the fastest rate. Because of rising health-care costs and expanded initiatives to facilitate the deployment of advanced particle therapy technologies in Asia Pacific countries, the Asia-Pacific region is expected to provide significant growth opportunities for particle therapy market participants.
The North American region is expected to grow at a CAGR of 6.9% during the forecast period. The North American market is expanding because of early adoption of innovative medical care and the availability of more particle therapy centres.
Scope of the Report:
|
Report Coverage |
Details |
|
Base year |
2021 |
|
Forecast period |
2022-2030 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 9.1% |
|
YoY growth (%) |
XX% |
|
Regional analysis |
|
|
Current Market size |
USD 814.1 million |
|
Companies Covered |
|
User
Tab Content
Introduction
Our market research is an extensive, iterative process that takes into account a combination of primary and secondary research tools with the aim of minimizing deviation and producing the most precise estimate and prediction. For the future course of action, this approach meticulously outlines the actual changes and industry trends. It gives incredibly valuable data that is drawn from the insights and opinions of analysts and professionals. Our papers include in-depth research and analysis based on several factual inputs obtained from expert interviews, accurate data, and local information.
Market Size Estimation
The overall size of the market has been estimated and validated using both top-down and bottom-up methods. The sizes of other market subsegments have also been thoroughly estimated using these methodologies.
In the top-down technique, the market is divided into segments based on the percentage share of each segment. This method assisted in determining the size of each segment's market. The market size of each segment and its sub-segments was then divided into regional market sizes. This Approach helps mainly with the new Product Launch. It uses Multi-variate Regression Model coupled with Vendor based primary research inputs to forecast to the Market Size.
In the Bottom-Up approach, comprehensive study of key players has to be done wherein we add the market size of the major key players to understand the national market size which helps to determine the regional market size and eventually the complete market size. Companies annual report along with data from paid and unpaid resources like reports from government agencies and organizations like world bank provide the data for this approach.
Avail 25% Discount
Report Benefits
-
Free Customization Available
-
30% discount on your next purchase
-
Dedicated account manager
-
Query resolution within 24 hours
-
Permission to print the report